A jar of HiPP baby food sold at SPAR supermarkets in Austria tested positive for rat poison, prompting a precautionary recall announced on April 18-19, 2026. Austrian police in Burgenland said a 190g jar of carrot-and-potato puree for infants was reported by a customer in the Eisenstadt area and laboratory analysis confirmed the presence of a toxic rodenticide. HiPP and SPAR removed affected stock from about 1,000–1,500 SPAR stores in Austria; similar jars seized in the Czech Republic and Slovakia also showed traces of a toxic substance. HiPP said the incident appears to be an external criminal interference affecting the SPAR Austria distribution channel and warned consumption could be life-threatening. Authorities advised customers not to eat the product, to return jars for a full refund, to wash hands after contact and to seek medical help if ingestion is suspected. Investigations are ongoing in Austria, Germany, the Czech Republic and Slovakia. No confirmed illnesses have been reported so far.

Jordan Peterson is suffering a relapse of akathisia linked by his daughter to an “old neurological injury” she says was induced by prior psychiatric medication use, according to a video update shared on social media in mid‑April 2026. Mikhaila Peterson said her father experienced a flare last summer after what the family believes was mould exposure and chronic inflammatory response syndrome (CIRS), compounded by stress from recent bereavements, relocation and the sale of the family home. She said the episode was complicated by pneumonia and sepsis and that Peterson — who has previously spoken publicly about benzodiazepine dependence and withdrawal — has not taken psychiatric medication for several years. The daughter described months of severe daily distress before doctors reached the current diagnosis and said his condition is now improving as they avoid triggers and pursue recovery. Mikhaila said she will not provide further updates while the family focuses on healing, and has launched a resource site to raise awareness of what she terms psych‑med injuries.

Andrew Lloyd Webber, the 78-year-old composer behind Phantom of the Opera, Cats and other hit musicals, has told The Times he is a “recovering alcoholic.” In an interview published Apr. 18, 2026, Lord Lloyd-Webber said he sought help about 16 months ago after a period he described as a “downhill spiral” that left his family “in a desperate state.” He initially checked into a clinic, which he said didn’t work, and later began attending Alcoholics Anonymous meetings – now taking part daily whether at his homes in London, Hampshire or New York. Lloyd-Webber said he had briefly stopped drinking in 2015–16 but relapsed, often drinking in secret, and that attending AA was life-changing. He credited family support, wears bracelets bearing his late son Nicholas’s name and a link from his other children, and said sobriety has not diminished his creative output; he is working on two new musicals and has recent productions on Broadway. Lloyd-Webber is also selling the remainder of his wine collection via Christie’s, with auctions scheduled Apr. 22–May 6.

Dancing With the Stars judge Carrie Ann Inaba was rushed to hospital after a mid‑flight medical emergency while flying from Los Angeles to New York on April 16, 2026, she said in an Instagram post. Inaba, 58, described suddenly feeling very ill — breaking out into a cold sweat, becoming dizzy and experiencing numbness in her arms — symptoms that prompted a call for medical help aboard the plane. Doctors on board and flight crew assisted; paramedics met the aircraft and took her to an emergency room. During the ambulance ride her blood pressure briefly dropped, she said, but she was later stabilized, discharged and returned to her hotel. Inaba, who has publicly discussed multiple autoimmune conditions including lupus, Sjögren’s syndrome, fibromyalgia and rheumatoid arthritis, said the episode did not appear tied to her Sjögren’s diagnosis. She thanked the medical personnel, flight staff and fellow passengers who helped, and apologized for cancelling scheduled interviews and appearances while she rests and recovers.

Researchers at the University of Pittsburgh/UPMC reported early-stage clinical trial results showing donor-derived regulatory dendritic cells can prime recipients’ immune systems to accept living-donor liver grafts without lifelong immunosuppression. The Phase I/IIa study, published in Nature Communications on April 17–18, 2026, enrolled 13 living-liver transplant recipients who received an infusion of dendritic regulatory cells derived from donor monocytes one week before surgery. One year after transplant, eight patients were eligible for stepwise withdrawal of anti-rejection drugs; four achieved complete withdrawal and three have remained off immunosuppression for more than three years. Investigators describe the approach as feasible and preliminarily safe, with a 37.5% withdrawal success among those eligible versus roughly 13–16% historically. Authors and commentators caution the trial was small and not randomized, and they call for larger controlled studies to confirm efficacy, optimize timing and regimens, and evaluate use with deceased donors or alternative immunosuppressant protocols.